title: 68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer.
abstract: A 64-year-old man with prostate cancer and an increasing prostate-specific antigen (PSA) level under therapy with abiraterone acetate underwent a therapy with Ra. Before the first therapy and 4 weeks after the last cycle, the patient underwent Ga-PSMA PET, which showed a clear response of bone metastases.
authors.affiliation: From the *Department of Nuclear Medicine, University Hospital Bonn, Bonn; and †Department of Urology, University Hospital Bonn, Bonn, Germany.
authors.forename: Hojjat
authors.initials: H
authors.lastname: Ahmadzadehfar
authors.forename: Carl Diedrich
authors.initials: CD
authors.lastname: Schlenkhoff
authors.forename: Sebastian
authors.initials: S
authors.lastname: Rogenhofer
authors.forename: Anna
authors.initials: A
authors.lastname: Yordanova
authors.forename: Markus
authors.initials: M
authors.lastname: Essler
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D004492:Edetic Acid / Q000031:analogs & derivatives; D005709:Gallium Isotopes; D005710:Gallium Radioisotopes; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides; D009942:Organometallic Compounds; D049268:Positron-Emission Tomography / Q000379:methods*; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000473:pathology*; D011868:Radioisotopes / Q000627:therapeutic use; D011883:Radium / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D005709:Gallium Isotopes; D005710:Gallium Radioisotopes; D009842:Oligopeptides; D009942:Organometallic Compounds; D011868:Radioisotopes; C000718244:gallium 68 PSMA-11; D004492:Edetic Acid; D017430:Prostate-Specific Antigen; C581106:radium Ra 223 dichloride; D011883:Radium